Abbott Laboratories buy Royal Bank of Canada
Start price
14.02.24
/
50%
€104.16
Target price
14.02.25
€119.35
Performance (%)
-1.37%
Price
17:45
€102.22
Summary
This prediction is currently active. With a performance of -1.37%, the BUY prediction for Abbott Laboratories by Royal_Bank_of_Canada is down slightly. A total of €0.52 was paid as dividends for this prediction. This prediction currently runs until 14.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | 1.131% | 1.131% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $128.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.54
25.01.24
25.01.24
€118.09
25.01.25
25.01.25
0.46%
17:45
17:45
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.98
11.01.24
11.01.24
€116.90
11.01.25
11.01.25
0.52%
17:45
17:45